Nabumetone Tablet, Film Coated
Product Images NDC 70954-784

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 70954-784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
FDA Label Image

Label-1 (Label 1)

Label-1 (Label 1)
This is a medication label for Nabumetone tablets in a dosage of 500 mg. The tablets should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). Each tablet contains 500 mg of Nabumetone and it is recommended to refer to the package insert for full prescribing information. The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. The medication guide should be given to each patient, and it is for prescription use only.*
FDA Label Image

Label-2 (Label 2)

Label-2 (Label 2)
This is a description of Nabumetone 500 mg Tablets, USP, with information on dosage, storage instructions, and safety precautions. It also includes details on the distribution by ANI Pharmaceuticals, Inc. The text emphasizes providing a Medication Guide to each patient and keeping the medication out of reach of children. The usual dosage recommendations are available in the package insert. The tablets should be stored between 20°C to 25°C and protected in a tight, light-resistant container with a child-resistant closure as per USP guidelines.*
FDA Label Image

Label-3 (Label 3)

Label-3 (Label 3)
FDA Label Image

Label-4 (Label 4)

Label-4 (Label 4)
This is a description of Nabumetone tablets, USP 750 mg. It includes information on the usual dosage, storage instructions, and the necessity to dispense a Medication Guide to each patient. The tablets are to be kept in a tight, light-resistant container with a child-resistant closure. The medication is distributed by ANI Pharmaceuticals, Inc. located in Baudette, MN.*
FDA Label Image

Structure-2 (Structure 2)

Structure-2 (Structure 2)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.